Q1 2021
Released Apr 5, 2021, before the open
10-Q filed May 6, 2021, 36 days after period end · 0001493152-21-010619
Q1 2021 · 10-Q
Revenue$2.74M$2.74M +8.2% vs Q1 2020+17.2% vs Q4 2020
Net Income-$537.00K-$537.00K N/M vs Q1 2020N/M vs Q4 2020
EPS Diluted-$0.06-$0.06 N/M vs Q1 2020no prior Q4 2020 on file
Gross Profit$1,587,000+6.4%
Operating Income-$1,018,000N/M
Operating Cash Flow-$55,000N/M
Free Cash Flowderived-$78,000—
Margins · derived
Gross margin58.0%−1.0 pt vs Q1 2020
Operating margin-37.2%+3.4 pt vs Q1 2020
Net margin-19.6%+23.8 pt vs Q1 2020
What the release said
The release
Same quarter
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | $2.74M | $2.53M | $1.77M | $985.00K |
| Net Income | -$537.00K | -$1.10M | -$1.35M | -$1.43M |
| EPS Diluted | -$0.06 | -$0.13 | -$0.20 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR